🌏 中文 | English

Hyphens Pharma (1J5) Annual Reports

HYPHENS PHARMA INTL LIMITED ・ Listed on the Catalist of the Singapore Exchange, classified under Wholesale and Retail Trade. This page collects the company's annual and sustainability reports, with PDFs served directly by SGX.

Sector
All Retail & Trading stocks →
Listing date
2018-05-18
Incorporated
2017-12-12
Place of incorporation
SINGAPORE
Website
Official site ↗
8
annual reports
4
sustainability reports
2025
latest year

What Hyphens Pharma does

Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapores leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Groups regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based.

The Groups core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.

Company profile as published by the Singapore Exchange.

Hyphens Pharma filings by year

Year Annual ReportSustainability Report
2025 PDF PDF
2024 PDF
2023 PDF
2022 PDF
2021 PDF PDF
2020 PDF PDF
2019 PDF PDF
2018 PDF

About Hyphens Pharma annual reports

Where can I download Hyphens Pharma (1J5) annual reports?

Every year in the table above links straight to the PDF filed with the Singapore Exchange (SGX). 8 annual reports are indexed, covering 2018 to 2025.

Do Singapore listed companies publish quarterly reports?

Mostly not. SGX removed mandatory quarterly reporting in 2020 in favour of a risk-based regime — only issuers meeting certain criteria still have to file quarterly. Most companies therefore publish just a half-year report and an annual report. The small number of quarterly filings indexed here reflects the rules, not missing data.

What is a sustainability report?

Since 2016 SGX has required listed issuers to publish a sustainability report covering environmental, social and governance (ESG) matters. It is a separate document from the annual report; both are indexed here.

What is the difference between the Mainboard and Catalist?

Catalist has lower entry requirements and targets smaller, growing companies, supervised through a sponsor regime; the Mainboard sets higher profit and market-capitalisation thresholds. Reporting obligations are broadly similar.

Source: Singapore Exchange (SGX). All PDF links point to the original files; nothing is re-hosted here.
Browse all Singapore listed companies, or read this page in Chinese.